Myeloid Cell Leukemia-1 (MCL-1) Inhibitor

Overview

MCL-1 is a protein found in our bodies that some of our cells use to maintain normal function and protect themselves. Researchers have found that certain kinds of cancer cells have a large amount of this protein. This may contribute to the cancer cells ability to rapidly grow, and help it protect itself from anticancer therapy.

A new type of drug, an MCL-1 inhibitor, is being tested for use in multiple myeloma. Researchers think they could work by preventing cancer cells from using the MCL-1 protein, which may cause cell death.

Explore Tags

Myeloma Treatments

The following is a listing of myeloma treatments associated with this tag.

All Treatments

View all treatments in development for myeloma patients around the US.

Early Relapse Multiple Myeloma

The following is a listing of treatments in development for patients with multiple myeloma who have received one to two prior lines of therapy.

Late Relapse Multiple Myeloma

The following is a listing of treatments in development for patients with multiple myeloma who have received three or more prior lines of therapy.

Myeloma Clinical Trials

The following is a listing of myeloma clinical trials associated with this tag.

Resources

There are no resources, links or videos to display for this tag.